Filing metadata

Accession number
0001127602-25-021248
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Sep 10, 2025
Reporting period
Sep 08, 2025
Description
Insider transaction

Explore SEC Filings Hub